OHSU
Portland, Oregon, 97239, United States
NCT Number: NCT01931904
The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
This study is active but is not currently recruiting participants.
Notify Me18 year–85 year
All sexes
Observational
Portland, Oregon, 97239, United States
Using high-speed ocular coherence tomography (OCT) systems, we have developed new methods to image and measure optic nerve head (ONH) and retinal blood flow. Preliminary results have shown that visual field (VF) loss is more highly correlated with retinal blood flow as measured by OCT than any neural structure measured by OCT or other imaging modality. Accordingly, the goal of the proposed project is to improve the diagnostic and prognostic evaluation of glaucoma by further developing novel functional OCT measurements using ultrahigh-speed (70-100 kHz) OCT technology.
Retinal blood flow, ONH circulation, optic disc rim volume, peripapillary nerve fiber layer volume, and macular ganglion cell complex volume are all pieces of the same glaucoma puzzle. This project will develop novel imaging methods that allow us to look at the whole picture using one tool - ultrahigh-speed OCT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Subjects will be evaluated on enrollment (pre-operatively) and at post-operative visits ( 3, 6, 12, 18, and 24-months post-op).
To determine if IOP reduction improves ocular perfusion. Change in IOP reduction will be measured in mmHg.
Oregon Health and Science University
Other
Observational Study of Ocular Blood Flow Pre- and Post- Glaucoma Surgery Using Functional and Structural Optical Coherence Tomography
Acronym: IOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07643077
Eye Diseases, Glaucoma
Ioannina, Epirus, Greece
View Trial DetailsNCT05626491
Eye Diseases, Glaucoma
Palo Alto, California, United States
View Trial DetailsNCT07480603
Eye Diseases, Glaucoma
Sali, Senegal
View Trial DetailsNCT06666751
Eye Diseases, Glaucoma
Murray, Utah, United States
View Trial Details